Tourmaline Bio, Inc (TRML)
NGM · Common · CUSIP 89157D105
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for TRML and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
89157D105 (prev. 87410C104 )
Market Cap
Small Cap
IPO
5/10/2021 · $17.00/share
Previous Symbol
TALS (changed 10/20/2023)
Previous Name
Talaris Therapeutics, Inc.
Business: Tourmaline Bio, Inc is a late-stage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients with life-altering immune and inflammatory diseases.

Company Contact

CEO
Sandeep Kulkarni
CFO
Ryan Robinson
Headquarters
27 West 24th Street, Suite 702, New York, NY 10010
Phone
502-398-9250
Investor Relations
Lee M. Stern, Meru Advisors · lstern@meruadvisors.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »